首页> 外文OA文献 >A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China

【2h】

A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China

机译：用于新诊断，复发或难治的外杀鼠/ T细胞淋巴瘤，鼻腔类型的甲氨蝶呤，依托泊苷，地塞米松和PEGASPARGASE和PEGASPARGASE化学疗法的第2期研究：中国西北部的多中心试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Rong Liang; Guang-xun Gao; Jie-ping Chen; Ji-shi Wang; Xiao-min Wang; Yun Zeng; Qing-xian Bai; Tao Zhang; Lan Yang; Bao-xia Dong; Hong-tao Gu; Mi-mi Shu; Cai-xia Hao; Jian-hong Wang; Na Zhang; Xie-qun Chen;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T‐cell lymphoma, nasal type: a multicenter trial in Northwest China [J] . Liang Rong, Gao Guang‐xun, Chen Jie‐ping, Hematological oncology . 2017,第4期

机译：甲氨蝶呤，依托泊苷，地塞米松和Pegaspargase化疗的第2期研究，用于新诊断，复发或难治的外侧自然杀伤/ T细胞淋巴瘤，鼻型：中国西北部的多中心试验
2. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type [J] . Peng-Peng Xu, Jie Xiong, Shu Cheng, EBioMedicine . 2017,第4期

机译：甲氨蝶呤，依托泊苷，地塞米松和Pegaspargase夹心放疗的II期研究，用于治疗新诊断的IE到IIE结外型自然杀手/ T细胞淋巴瘤（鼻型）
3. A study of gemcitabine, L-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type [J] . Ji Jie, Liu Ting, Xiang Bing, Leukemia and lymphoma . 2014,第12期

机译：吉西他滨，L-天冬酰胺酶，异环磷酰胺，地塞米松和依托泊苷化学疗法用于新诊断的IV期，复发性或难治性结外自然杀伤/ T细胞淋巴瘤，鼻型的研究
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. A phase 2 study of methotrexate etoposide dexamethasone and pegaspargase chemotherapy for newly diagnosed relapsed or refractory extranodal natural killer/T‐cell lymphoma nasal type: a multicenter trial in Northwest China [O] . Rong Liang, Guang‐xun Gao, Jie‐ping Chen, -1

机译：甲氨蝶呤依托泊苷地塞米松和培加aspargase化疗用于新诊断复发或难治性结外性自然杀伤/ T细胞淋巴瘤鼻型的2期研究：一项在西北地区的多中心试验
6. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type [O] . Peng-Peng Xu, Jie Xiong, Shu Cheng, 2017

机译：甲氨蝶呤，依托咪酯，地塞米松和pegaspargase夹心放射治疗新诊断的IE-IIE结外自然杀伤/ T细胞淋巴瘤，鼻型的II期研究

A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China

著录项

相似文献

相关主题

期刊订阅